Half-year report · HY
9913.TEDINET S100WZX2
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥44.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥946m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥839m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥979m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥982m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥685m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥672m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥686m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥672m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥33.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥32.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥32.8bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥15.9bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥16.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.5bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥427m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥979m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥629m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥604m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥872m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥236m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥75.88 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥155.15 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.75 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥101m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥101m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥149m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥149m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥734m |
| Electronicsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥10.1bn |
| Electronicsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥10.0bn |
| Electronicsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥47m |
| Electronicsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥827m |
| Mobilityreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥8.5bn |
| Mobilityreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥8.5bn |
| Mobilityreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥0 |
| Mobilityreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥475m |
| Precision Medical Machineryreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Precision Medical Machineryreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Precision Medical Machineryreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥0 |
| Precision Medical Machineryreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥348m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥22.2bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥22.2bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥48m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥22.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥22.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥149m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥109m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥109m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥32m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥202m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥202m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥672m |
| Electronicsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥10.4bn |
| Electronicsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥10.4bn |
| Electronicsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥28m |
| Electronicsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥828m |
| Mobilityreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥8.2bn |
| Mobilityreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥8.2bn |
| Mobilityreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥64m |
| Mobilityreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥468m |
| Precision Medical Machineryreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.5bn |
| Precision Medical Machineryreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.5bn |
| Precision Medical Machineryreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| Precision Medical Machineryreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥182m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥22.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥22.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥93m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥22.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥22.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥202m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 551
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |